Litcius/Paper detail

Advances in Chondroitin Sulfate-Based Nanoplatforms for Biomedical Applications

Cunming Peng, Anna Zheng, Liangliang Wang, Yingjie Shen, Changchun Peng, Jingmou Yu, Shengwen Shao

2025International Journal of Nanomedicine7 citationsDOIOpen Access PDF

Abstract

Chondroitin sulfate (CS) is a naturally sulfated glycosaminoglycan with diverse biofunctional properties, including anti-inflammatory effects, reactive oxygen species scavenging, cartilage regeneration and immune regulation. In recent years, CS has shown significant progress in biomedical applications, particularly in drug delivery, tissue engineering, and biosensing. This paper reviews the latest advancements of CS-based nanoplatforms in the biomedical field. CS can be integrated with functional molecules to construct a variety of nanostructures, further expanding its potential applications. CS exhibits distinctive characteristics, and CS-based nanoparticles could serve as promising drug delivery vehicles in tumor therapy. Beyond their roles in drug delivery, CS-based nanoplatforms exhibit transformative potential in tissue engineering, offering promising solutions for wound repair and tissue regeneration. Additionally, CS enhances early disease diagnostics through biomarker detection, leveraging its unique molecular structure and biocompatibility. This comprehensive review explored the properties of CS-based nanoplatforms and their diverse applications, aiming to provide a reference for related research and encourage further advancements in the biomedical fields.

Topics & Concepts

NanotechnologyDrug deliveryBiocompatibilityTissue engineeringRegeneration (biology)Materials scienceChondroitin sulfateNanomedicineBiomedical engineeringChemistryNanoparticleMedicineGlycosaminoglycanBiologyCell biologyMetallurgyBiochemistryProteoglycans and glycosaminoglycans researchElectrospun Nanofibers in Biomedical ApplicationsCorneal Surgery and Treatments
Advances in Chondroitin Sulfate-Based Nanoplatforms for Biomedical Applications | Litcius